
Dhanya K. Nambiar, PhD, Stanford University, discusses a study exploring galectin-1 in combination with radiation and immune checkpoint therapy in head and neck cancers.

Your AI-Trained Oncology Knowledge Connection!


Published: May 26th 2017 | Updated: